These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30129250)

  • 21. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
    Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
    J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.
    Boy N; Mühlhausen C; Maier EM; Heringer J; Assmann B; Burgard P; Dixon M; Fleissner S; Greenberg CR; Harting I; Hoffmann GF; Karall D; Koeller DM; Krawinkel MB; Okun JG; Opladen T; Posset R; Sahm K; Zschocke J; Kölker S;
    J Inherit Metab Dis; 2017 Jan; 40(1):75-101. PubMed ID: 27853989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I.
    Jafari P; Braissant O; Zavadakova P; Henry H; Bonafé L; Ballhausen D
    PLoS One; 2013; 8(1):e53735. PubMed ID: 23326493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention by L-carnitine of DNA damage induced by 3-hydroxy-3-methylglutaric and 3-methylglutaric acids and experimental evidence of lipid and DNA damage in patients with 3-hydroxy-3-methylglutaric aciduria.
    Delgado CA; Balbueno Guerreiro GB; Diaz Jacques CE; de Moura Coelho D; Sitta A; Manfredini V; Wajner M; Vargas CR
    Arch Biochem Biophys; 2019 Jun; 668():16-22. PubMed ID: 31047871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency.
    Hennermann JB; Roloff S; Gellermann J; Grüters A; Klein J
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S355-9. PubMed ID: 20033292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
    Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
    Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute lysine overload provokes protein oxidative damage and reduction of antioxidant defenses in the brain of infant glutaryl-CoA dehydrogenase deficient mice: a role for oxidative stress in GA I neuropathology.
    Seminotti B; Ribeiro RT; Amaral AU; da Rosa MS; Pereira CC; Leipnitz G; Koeller DM; Goodman S; Woontner M; Wajner M
    J Neurol Sci; 2014 Sep; 344(1-2):105-13. PubMed ID: 24996493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes.
    Colín-González AL; Paz-Loyola AL; Serratos IN; Seminotti B; Ribeiro CA; Leipnitz G; Souza DO; Wajner M; Santamaría A
    Neuroscience; 2015 Dec; 310():578-88. PubMed ID: 26431622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of BDNF and cathepsin-d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I.
    Guerreiro G; Diaz Jaques CE; Wajner M; Vargas CR
    Int J Dev Neurosci; 2020 Feb; 80(1):42-49. PubMed ID: 31910296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.
    Ribas GS; Biancini GB; Mescka C; Wayhs CY; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2012 Jan; 32(1):77-82. PubMed ID: 21833551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
    Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mass spectrometry combined with gene analysis for prenatal diagnosis of glutaric acidemia type Ⅰ].
    Han F; Han LS; Ji WJ; Chen T; Xu F; Wang Y; Ye J; Qiu WJ; Zhang HW; Jiang YZ; Hou C; Gu XF
    Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):539-543. PubMed ID: 28728265
    [No Abstract]   [Full Text] [Related]  

  • 34. Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.
    Boy N; Haege G; Heringer J; Assmann B; Mühlhausen C; Ensenauer R; Maier EM; Lücke T; Hoffmann GF; Müller E; Burgard P; Kölker S
    J Inherit Metab Dis; 2013 May; 36(3):525-33. PubMed ID: 22971958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m-Trifluoromethyl diphenyl diselenide attenuates glutaric acid-induced seizures and oxidative stress in rat pups: involvement of the γ-aminobutyric acidergic system.
    Magni DV; Brüning CA; Gai BM; Quines CB; Rosa SG; Fighera MR; Nogueira CW
    J Neurosci Res; 2012 Sep; 90(9):1723-31. PubMed ID: 22535575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I.
    Vendramin Pasquetti M; Meier L; Loureiro S; Ganzella M; Junges B; Barbieri Caus L; Umpierrez Amaral A; Koeller DM; Goodman S; Woontner M; Gomes de Souza DO; Wajner M; Calcagnotto ME
    Epilepsia; 2017 Oct; 58(10):1771-1781. PubMed ID: 28762469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Korean patient with glutaric aciduria type 1 with a novel mutation in the glutaryl CoA dehydrogenase gene.
    Kim HS; Yu HJ; Lee J; Park HD; Kim JH; Shin HJ; Jin DK; Lee M
    Ann Clin Lab Sci; 2014; 44(2):213-6. PubMed ID: 24795062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher Vulnerability of Menadione-Exposed Cortical Astrocytes of Glutaryl-CoA Dehydrogenase Deficient Mice to Oxidative Stress, Mitochondrial Dysfunction, and Cell Death: Implications for the Neurodegeneration in Glutaric Aciduria Type I.
    Rodrigues MDN; Seminotti B; Zanatta Â; de Mello Gonçalves A; Bellaver B; Amaral AU; Quincozes-Santos A; Goodman SI; Woontner M; Souza DO; Wajner M
    Mol Neurobiol; 2017 Aug; 54(6):4795-4805. PubMed ID: 27510504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Recovery of a GCDH Variant Associated to Severe Deflavinylation-Molecular Insights into Potential Beneficial Effects of Riboflavin Supplementation in Glutaric Aciduria-Type I Patients.
    Ribeiro JV; Gomes CM; Henriques BJ
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular investigation in Chinese patients with glutaric aciduria type I.
    Zhang Y; Li H; Ma R; Mei L; Wei X; Liang D; Wu L
    Clin Chim Acta; 2016 Jan; 453():75-9. PubMed ID: 26656312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.